Dieter Egli, a NYSCF Senior Research Fellow, contributed to a study published in Molecular Medicine that provides direct evidence of sight-loss recovery using induced pluripotent stem...
Dung-Fang Lee, PhD, a NYSCF – Druckenmiller Fellow Alumnus at Mount Sinai School of Medicine, has published a new study in the August edition of Cell...
Marius Wernig, MD, a NYSCF – Robertson Investigator at Stanford University, released an update to previously published work confirming that mouse skin cells can bypass the...
Sriram Bandi, PhD, a NYSCF – Druckenmiller Fellowship alumnus, published work in the February 2012 Journal of Cell Science finding that cells derived from a human...
Interviewed for Drug Discovery News, NYSCF CEO Susan L. Solomon and NYSCF Vice President of Research and Development Stephen Chang, PhD, revealed the potential for stem...
For a weekend in Washington, DC, “Celebration of Science” convened academic, pharmaceutical, biotech, and governmental leaders to share prominent scientific advances. NYSCF CEO Susan L. Solomon...
June 12 – 15, 2013 | Boston Convention and Exhibition Center (BCEC), Boston, MA USA The International Society for Stem Cell Research (ISSCR)’s annual meeting has...
At NYCTech Connect’s Riverside Chat event, NYSCF CEO Susan L. Solomon engaged an audience at Memorial Sloan-Kettering Cancer Center, recounting the founding of NYSCF. She revealed...
In six papers published in Nature, the results of the federally funded effort ENCODE (Encyclopedia of DNA Elements) that extended over 32 labs and involved 440...
Giuseppe Maria de Peppo, PhD, a Postdoctoral Research Fellow at the NYSCF Laboratory, was honored by his native Italian province of Puglia with the Argos Hippium...
Tackling the question of why some cells become cancerous, Ravi Majeti, MD, PhD, a NYSCF – Robertson Investigator, and researchers at Stanford University made a landmark...
Darja Marolt, PhD, a NYSCF – Helmsley Investigator, is author on a paper from work undertaken as a postdoctorate published in Biomaterials, in which she and...
In the August 27th edition of Tissue Engineering, Giuseppe de Peppo, PhD, a NYSCF Postdoctoral Research Fellow, published results of a study from his graduate work...
Published in Nature, a study led by KJ Patel has revealed how alcohol can damage hematopoietic (or blood) stem cells. When mice lacked an enzyme that...
Researchers led by Janet Rossant at the University of Toronto and the Hospital for Sick Children have reprogrammed cystic fibrosis patients’ skin samples into induced pluripotent...
After a three-year legal battle, US Court of Appeals has upheld the District Court’s decision that permits federal funding of human embryonic stem cell (hESC) research....
Dieter Egli, PhD, a NYSCF Senior Research Fellow, is co-author on a paper published in the August 19th edition of Nature Genetics, a study conducted in...
The FDA has approved the first clinical trial to determine the safety and efficacy of cord blood stem cells in the treatment of autism. The study,...
At the Alzheimer’s Association International Conference this past July, Andrew Sproul, PhD, a NYSCF Postdoctoral Associate, presented NYSCF’s latest efforts to understand Alzheimer’s disease. They have...
Dieter Egli, a NYSCF Senior Research Fellow, contributed to a study published in Molecular Medicine that provides direct evidence of sight-loss recovery using induced pluripotent stem...
Last month, Shinya Yamanaka obtained approval from the Japanese health-ministry committee to create stem cell lines from fetal umbilical-cord blood (UCB) samples. This is a formative...
A paradigm shift may be underway: three separate studies have confirmed the presence of cancer stem cells that drive tumor growth. The studies’ findings, published in...
Dung-Fang Lee, PhD, a NYSCF – Druckenmiller Fellow Alumnus at Mount Sinai School of Medicine, has published a new study in the August edition of Cell...
A team of scientists at The New York Stem Cell Foundation (NYSCF) Laboratory led by Scott Noggle, PhD, NYSCF–Charles Evans Senior Research Fellow for Alzheimer’s Disease,...
“We have something that will radically save the pharmaceutical industry,” says Susan Solomon in an interview on the social floor of TEDGlobal 2012, in Edinburgh, Scotland....
